imfinzi (durvalumab)- non-small cell lung cancer (nsclc)
Published 10 months ago • 21 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
2:58
patients reportedly beating cancer with just one tablet a day | 9 news australia
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
52:55
immunotherapy nightmare - imfinzi/durvalumab experience - lung cancer
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
7:45
onctalk 2021 - pdl1 and imfinzi/durvalumab
-
10:15
what tumors eat -- and how to poison them | dr. christal sohl | tedxtulsacc
-
3:24
'tumors just vanished': cancer patients now in remission after drug trial
-
2:44
how is immunotherapy used to fight cancer? | dana-farber cancer institute | science illustrated
-
8:28
imfinzi uses: guide to understanding the many benefits of this breakthrough immunotherapy
-
6:06
stage iii nsclc: when to start durvalumab
-
2:10
poseidon: 4 year follow up of durvalumab and tremelimumab in nsclc
-
8:16
case based panel discussion - stage 3 nsclc best schedule - durvalumab/imfinzi in varying patients
-
1:18
imfinzi® (durvalumab) plus chemotherapy approved in the us as the first immunotherapy regimen...
-
1:08
dr. bazhenova on the pacific trial with durvalumab in nsclc
-
1:20
dr. simon on durvalumab for patients with lung cancer
-
1:42
dr. feldman on the future of durvalumab and tremilimumab in nsclc
-
2:13
lung cancer video library - immunotherapy in stage lll nsclc - the pacific trial and imfinzi
-
14:33
moa of imfinzi in 1l mnsclc
-
3:01
hope for patients with non-small cell lung cancer
-
0:31
is it non small cell or small cell?